Risk factors, treatment and prognosis of patients with lung cancer after heart transplantation

Long-term survival after heart transplantation (HTX) is impacted by adverse effects of immunosuppressive pharmacotherapy, and post-transplant lung cancer is a common occurrence. This study aimed to examine the risk factors, treatment, and prognosis of patients with post-transplant lung cancer. We in...

Full description

Saved in:
Bibliographic Details
Main Authors: Heil, Karsten M. (Author) , Helmschrott, Matthias (Author) , Darche, Fabrice Fernand (Author) , Bruckner, Thomas (Author) , Ehlermann, Philipp (Author) , Kreußer, Michael (Author) , Dösch, Andreas (Author) , Sommer, Wiebke (Author) , Warnecke, Gregor (Author) , Frey, Norbert (Author) , Rivinius, Rasmus (Author)
Format: Article (Journal)
Language:English
Published: 4 December 2021
In: Life
Year: 2021, Volume: 11, Issue: 12, Pages: 1-15
ISSN:2075-1729
DOI:10.3390/life11121344
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/life11121344
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2075-1729/11/12/1344
Verlag, kostenfrei, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707242
Get full text
Author Notes:Karsten M. Heil, Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey, Rasmus Rivinius

MARC

LEADER 00000caa a2200000 c 4500
001 1799632512
003 DE-627
005 20230427072622.0
007 cr uuu---uuuuu
008 220414s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/life11121344  |2 doi 
035 |a (DE-627)1799632512 
035 |a (DE-599)KXP1799632512 
035 |a (OCoLC)1341458999 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heil, Karsten M.  |e VerfasserIn  |0 (DE-588)1184827532  |0 (DE-627)1663723931  |4 aut 
245 1 0 |a Risk factors, treatment and prognosis of patients with lung cancer after heart transplantation  |c Karsten M. Heil, Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey, Rasmus Rivinius 
264 1 |c 4 December 2021 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.04.2022 
520 |a Long-term survival after heart transplantation (HTX) is impacted by adverse effects of immunosuppressive pharmacotherapy, and post-transplant lung cancer is a common occurrence. This study aimed to examine the risk factors, treatment, and prognosis of patients with post-transplant lung cancer. We included 625 adult patients who received HTX at Heidelberg Heart Center between 1989 and 2018. Patients were stratified by diagnosis and staging of lung cancer after HTX. Analysis comprised donor and recipient characteristics, medications including immunosuppressive drugs, and survival after diagnosis of lung cancer. A total of 41 patients (6.6%) were diagnosed with lung cancer after HTX, 13 patients received curative care and 28 patients had palliative care. Mean time from HTX until diagnosis of lung cancer was 8.6 ± 4.0 years and 1.8 ± 2.7 years from diagnosis of lung cancer until last follow-up. Twenty-four patients (58.5%) were switched to an mTOR-inhibitor after diagnosis of lung cancer. Multivariate analysis showed recipient age (HR: 1.05; CI: 1.01-1.10; p = 0.02), COPD (HR: 3.72; CI: 1.88-7.37; p < 0.01), and history of smoking (HR: 20.39; CI: 2.73-152.13; p < 0.01) as risk factors for post-transplant lung cancer. Patients in stages I and II had a significantly better 1-year (100.0% versus 3.6%), 2-year (69.2% versus 0.0%), and 5-year survival (53.8% versus 0.0%) than patients in stages III and IV (p < 0.01). Given the poor prognosis of late-stage post-transplant lung cancer, routine reassessment of current smoking status, providing smoking cessation support, and intensified lung cancer screening in high-risk HTX recipients are advisable. 
650 4 |a heart transplantation 
650 4 |a immunosuppression 
650 4 |a lung cancer 
650 4 |a malignancy 
650 4 |a mortality 
650 4 |a survival 
700 1 |a Helmschrott, Matthias  |d 1986-  |e VerfasserIn  |0 (DE-588)1063822068  |0 (DE-627)812634187  |0 (DE-576)423257323  |4 aut 
700 1 |a Darche, Fabrice Fernand  |d 1986-  |e VerfasserIn  |0 (DE-588)1074849833  |0 (DE-627)832587044  |0 (DE-576)442994982  |4 aut 
700 1 |a Bruckner, Thomas  |d 1956-  |e VerfasserIn  |0 (DE-588)136046215  |0 (DE-627)574429298  |0 (DE-576)300798768  |4 aut 
700 1 |a Ehlermann, Philipp  |d 1969-  |e VerfasserIn  |0 (DE-588)121563812  |0 (DE-627)705540855  |0 (DE-576)292774761  |4 aut 
700 1 |a Kreußer, Michael  |d 1980-  |e VerfasserIn  |0 (DE-588)132382385  |0 (DE-627)521949424  |0 (DE-576)260798495  |4 aut 
700 1 |a Dösch, Andreas  |d 1976-  |e VerfasserIn  |0 (DE-588)129172758  |0 (DE-627)390355798  |0 (DE-576)297522310  |4 aut 
700 1 |a Sommer, Wiebke  |d 1983-  |e VerfasserIn  |0 (DE-588)140917918  |0 (DE-627)623126710  |0 (DE-576)321354729  |4 aut 
700 1 |a Warnecke, Gregor  |d 1974-  |e VerfasserIn  |0 (DE-588)125001517  |0 (DE-627)370699629  |0 (DE-576)294612823  |4 aut 
700 1 |a Frey, Norbert  |e VerfasserIn  |0 (DE-588)141244976  |0 (DE-627)625824075  |0 (DE-576)322969514  |4 aut 
700 1 |a Rivinius, Rasmus  |d 1986-  |e VerfasserIn  |0 (DE-588)1071009834  |0 (DE-627)825504309  |0 (DE-576)432876103  |4 aut 
773 0 8 |i Enthalten in  |t Life  |d Basel : MDPI, 2011  |g 11(2021), 12, Artikel-ID 1344, Seite 1-15  |h Online-Ressource  |w (DE-627)718627156  |w (DE-600)2662250-6  |w (DE-576)365413682  |x 2075-1729  |7 nnas  |a Risk factors, treatment and prognosis of patients with lung cancer after heart transplantation 
773 1 8 |g volume:11  |g year:2021  |g number:12  |g elocationid:1344  |g pages:1-15  |g extent:15  |a Risk factors, treatment and prognosis of patients with lung cancer after heart transplantation 
856 4 0 |u https://doi.org/10.3390/life11121344  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2075-1729/11/12/1344  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707242  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220414 
993 |a Article 
994 |a 2021 
998 |g 1071009834  |a Rivinius, Rasmus  |m 1071009834:Rivinius, Rasmus  |d 910000  |d 910100  |d 50000  |e 910000PR1071009834  |e 910100PR1071009834  |e 50000PR1071009834  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 11  |y j 
998 |g 141244976  |a Frey, Norbert  |m 141244976:Frey, Norbert  |d 910000  |d 910100  |e 910000PF141244976  |e 910100PF141244976  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 125001517  |a Warnecke, Gregor  |m 125001517:Warnecke, Gregor  |d 910000  |d 910200  |e 910000PW125001517  |e 910200PW125001517  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 140917918  |a Sommer, Wiebke  |m 140917918:Sommer, Wiebke  |d 910000  |d 910200  |d 50000  |e 910000PS140917918  |e 910200PS140917918  |e 50000PS140917918  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 8 
998 |g 129172758  |a Dösch, Andreas  |m 129172758:Dösch, Andreas  |d 50000  |e 50000PD129172758  |k 0/50000/  |p 7 
998 |g 132382385  |a Kreußer, Michael  |m 132382385:Kreußer, Michael  |d 910000  |d 910100  |d 50000  |e 910000PK132382385  |e 910100PK132382385  |e 50000PK132382385  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
998 |g 121563812  |a Ehlermann, Philipp  |m 121563812:Ehlermann, Philipp  |d 910000  |d 910100  |e 910000PE121563812  |e 910100PE121563812  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 136046215  |a Bruckner, Thomas  |m 136046215:Bruckner, Thomas  |d 910000  |d 911800  |e 910000PB136046215  |e 911800PB136046215  |k 0/910000/  |k 1/910000/911800/  |p 4 
998 |g 1074849833  |a Darche, Fabrice Fernand  |m 1074849833:Darche, Fabrice Fernand  |d 910000  |d 910100  |e 910000PD1074849833  |e 910100PD1074849833  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1063822068  |a Helmschrott, Matthias  |m 1063822068:Helmschrott, Matthias  |d 910000  |d 910100  |e 910000PH1063822068  |e 910100PH1063822068  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1184827532  |a Heil, Karsten M.  |m 1184827532:Heil, Karsten M.  |d 910000  |d 910100  |e 910000PH1184827532  |e 910100PH1184827532  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1799632512  |e 4117848429 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 14.04.2022"],"recId":"1799632512","person":[{"display":"Heil, Karsten M.","given":"Karsten M.","role":"aut","family":"Heil"},{"display":"Helmschrott, Matthias","given":"Matthias","role":"aut","family":"Helmschrott"},{"role":"aut","family":"Darche","display":"Darche, Fabrice Fernand","given":"Fabrice Fernand"},{"display":"Bruckner, Thomas","given":"Thomas","family":"Bruckner","role":"aut"},{"family":"Ehlermann","role":"aut","given":"Philipp","display":"Ehlermann, Philipp"},{"display":"Kreußer, Michael","given":"Michael","family":"Kreußer","role":"aut"},{"family":"Dösch","role":"aut","given":"Andreas","display":"Dösch, Andreas"},{"display":"Sommer, Wiebke","given":"Wiebke","role":"aut","family":"Sommer"},{"display":"Warnecke, Gregor","given":"Gregor","family":"Warnecke","role":"aut"},{"role":"aut","family":"Frey","given":"Norbert","display":"Frey, Norbert"},{"display":"Rivinius, Rasmus","given":"Rasmus","family":"Rivinius","role":"aut"}],"name":{"displayForm":["Karsten M. Heil, Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey, Rasmus Rivinius"]},"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"4 December 2021"}],"relHost":[{"disp":"Risk factors, treatment and prognosis of patients with lung cancer after heart transplantationLife","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 23.06.20"],"pubHistory":["1.2011 -"],"language":["eng"],"part":{"extent":"15","pages":"1-15","issue":"12","text":"11(2021), 12, Artikel-ID 1344, Seite 1-15","year":"2021","volume":"11"},"origin":[{"dateIssuedKey":"2011","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2011-"}],"title":[{"title_sort":"Life","title":"Life","subtitle":"open access journal"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2075-1729"],"eki":["718627156"],"zdb":["2662250-6"]},"recId":"718627156"}],"id":{"doi":["10.3390/life11121344"],"eki":["1799632512"]},"physDesc":[{"extent":"15 S."}],"title":[{"title":"Risk factors, treatment and prognosis of patients with lung cancer after heart transplantation","title_sort":"Risk factors, treatment and prognosis of patients with lung cancer after heart transplantation"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a HEILKARSTERISKFACTOR4202